glp-1 success Q&A: Long-term of therapies hinges on more than just a prescription IBX members face GLP-1 drug

Nausea affects 20-28% of users depending on dose, typically peaking during dose escalation periods

Immune Reactivity: The FDA has previously flagged concerns that compounded peptides like BPC 157 carry risks of triggering unexpected immune or allergic reactions

A Physician Explains You may have heard the terms GLP-1 agents, Alzheimers, dementia, type 3 diabeteswondered how they connect, and whether drugs designed for diabetes (or weight loss) might also protect your brain

Methods A comprehensive review of the literature was conducted by searching scientific databases including PubMed, Scopus, and Web of Science

National Library of Medicine, National Institutes of Health, accessed on October 5, 2023, medlineplus.gov/druginfo/meds/a695033.html

WHERE IT TREATS Systemic delivers hydrating fluids and vital nutrients directly into the bloodstream for immediate effect